Icosapent Ethyl Capsule — FDA Drug Shortage

To Be Discontinued — Apotex Corp.

The FDA lists a drug shortage record for Icosapent Ethyl Capsule (capsule) from Apotex Corp. with status To Be Discontinued. The shortage was first posted on Apr 1, 2026.

Shortage details

Status
To Be Discontinued
Company
Apotex Corp.
Package NDC
60429-005-12
Dosage Form
Capsule
Presentation
Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12)
Initial Posting
Apr 1, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.